Literature DB >> 14673881

Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program.

Christopher G Goetz1, Peter A LeWitt, Meredith Weidenman.   

Abstract

The Unified Parkinson's Disease Rating Scale (UPDRS) is the most widely used scale for evaluation of clinical impairment in PD. Whereas the motor section has been studied intensively for clinimetric properties and has an associated training tape, the Activities of Daily Living (ADL) section has been studied less rigorously. In preparation for a multicenter study that planned to use the UPDRS ADL score as an outcome, the authors reviewed the UPDRS ADL scale and designed a teaching program to provide a uniform technique for data acquisition without changing any wording of the primary scale. The teaching program is composed of four components: overall guidelines, clarifying points, recommended strategies, and a teaching videotape. The videotape shows examples of interviewers assessing each ADL item with patients of different disability levels and provides a complete ADL assessment of a single patient. Systematic training and utilization of this teaching program offer the potential for more uniformity in results of ADL assessments conducted in clinical practice and multicenter, international studies of PD. The written materials and videotape belong to the Movement Disorder Society and are available by contacting the MDS central office. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Year:  2003        PMID: 14673881     DOI: 10.1002/mds.10591

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study.

Authors:  Cindy M de Frias; Roger A Dixon; Richard Camicioli
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

2.  Can focusing on UPDRS Part II make assessments of Parkinson disease progression more efficient?

Authors:  Cristina Sampaio
Journal:  Nat Clin Pract Neurol       Date:  2009-03

3.  Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.

Authors:  Sydney E Seidel; Barbara C Tilley; Peng Huang; Yuko Y Palesch; Kenneth J Bergmann; Christopher G Goetz; Christopher J Swearingen
Journal:  Parkinsonism Relat Disord       Date:  2011-10-21       Impact factor: 4.891

Review 4.  Cost effectiveness of pharmacotherapies in early Parkinson's disease.

Authors:  Karla M Eggert; Jens P Reese; Wolfgang H Oertel; Richard Dodel
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.

Authors:  Rosemarie M Bowler; Harry A Roels; Sanae Nakagawa; Marija Drezgic; Emily Diamond; Robert Park; William Koller; Russell P Bowler; Donna Mergler; Maryse Bouchard; Donald Smith; Roberto Gwiazda; Richard L Doty
Journal:  Occup Environ Med       Date:  2006-10-03       Impact factor: 4.402

6.  Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease.

Authors:  T Müller; C Erdmann; S Muhlack; D Bremen; H Przuntek; O Goetze; D Woitalla
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

7.  Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.

Authors:  M Capecci; R A Ricciuti; D Burini; V G Bombace; L Provinciali; M Iacoangeli; M Scerrati; M G Ceravolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

8.  Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.

Authors:  T Müller; L Ander; K Kolf; D Woitalla; S Muhlack
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

9.  Force coordination during bimanual task performance in Parkinson's disease.

Authors:  Stacey L Gorniak; Andre G Machado; Jay L Alberts
Journal:  Exp Brain Res       Date:  2013-06-29       Impact factor: 1.972

10.  Assessment of Parkinson disease manifestations.

Authors:  Joel S Perlmutter
Journal:  Curr Protoc Neurosci       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.